International Niemann–Pick Disease Alliance

INPDA Community Webinar Series: Cyclo Therapeutics – Phase 3 Trial

Join us on Wednesday June 30th at 7pm BST to hear an update direct from Cyclo Therapeutics regarding their Phase 3 Clinical trial of Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C:

The INPDA is pleased to welcome the following Cyclo Therapeutics representatives to present and answer your questions:
Gerald Cox, MD, PhD, Cyclo Therapeutics Acting Chief Medical Officer
Lori McKenna Gorski, Cyclo Therapeutics Global Head of Patient Advocacy
Sharon Hrynkow, PhD, Cyclo Therapeutics Chief Scientific Officer, Senior VP of Medical Affairs

Register in advance for this meeting:

After registering, you will receive a confirmation email containing information about joining the meeting

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

The Impact of NPC

The global community tell their stories...